{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T02:30:21Z","timestamp":1769913021897,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004242","name":"Princess Nourah bint Abdulrahman University","doi-asserted-by":"publisher","award":["PNURSP2025R30"],"award-info":[{"award-number":["PNURSP2025R30"]}],"id":[{"id":"10.13039\/501100004242","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","award":["RSPD2025R811"],"award-info":[{"award-number":["RSPD2025R811"]}],"id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jmgm.2025.109013","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T08:06:43Z","timestamp":1742198803000},"page":"109013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Targeting OPA1 protein for therapeutic intervention in autosomal dominant optic atrophy: In silico drug discovery"],"prefix":"10.1016","volume":"138","author":[{"given":"Azhar","family":"Iqbal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Sajid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guendouzi","family":"Abdelkrim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammara","family":"Riaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umar","family":"Farooq","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabana","family":"Bibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghadeer M.","family":"Albadrani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muath Q.","family":"Al-Ghadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amany A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Abdel-Daim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2025.109013_bib1","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1146\/annurev.biochem.76.071905.090048","article-title":"The machines that divide and fuse mitochondria","volume":"76","author":"Hoppins","year":"2007","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109013_bib2","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1523\/JNEUROSCI.4798-06.2007","article-title":"Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations","volume":"27","author":"Baloh","year":"2007","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.jmgm.2025.109013_bib3","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.cell.2007.06.026","article-title":"Mitochondrial fusion protects against neurodegeneration in the cerebellum","volume":"130","author":"Chen","year":"2007","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109013_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1083\/jcb.200211046","article-title":"Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development","volume":"160","author":"Chen","year":"2003","journal-title":"J. Cell Biol."},{"issue":"5\u20136","key":"10.1016\/j.jmgm.2025.109013_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.bbamcr.2006.02.004","article-title":"Get the balance right: mitofusins roles in health and disease","volume":"1763","author":"Santel","year":"2006","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.jmgm.2025.109013_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-004-1199-2","article-title":"Mitochondrial GTPase mitofusin 2 mutation in Charcot\u2013Marie\u2013Tooth neuropathy type 2A","volume":"116","author":"Kijima","year":"2005","journal-title":"Hum. Genet."},{"issue":"5","key":"10.1016\/j.jmgm.2025.109013_bib7","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/ng1341","article-title":"Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A","volume":"36","author":"Z\u00fcchner","year":"2004","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109013_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.preteyeres.2003.10.003","article-title":"Mitochondrial dysfunction as a cause of optic neuropathies","volume":"23","author":"Carelli","year":"2004","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jmgm.2025.109013_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1146\/annurev.cellbio.22.010305.104638","article-title":"Mitochondrial fusion and fission in mammals","volume":"22","author":"Chan","year":"2006","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109013_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/ICU.0000000000000314","article-title":"Dominant optic atrophy: updates on the pathophysiology and clinical manifestations of the optic atrophy 1 mutation","volume":"27","author":"Chun","year":"2016","journal-title":"Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jmgm.2025.109013_bib11","series-title":"Seminars in Pediatric Neurology","article-title":"Dominant optic atrophy and Leber's hereditary optic neuropathy: update on clinical features and current therapeutic approaches","author":"Chun","year":"2017"},{"issue":"7","key":"10.1016\/j.jmgm.2025.109013_bib12","first-page":"E692","article-title":"Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations","volume":"30","author":"Ferr\u00e9","year":"2009"},{"key":"10.1016\/j.jmgm.2025.109013_bib13","first-page":"1","article-title":"Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics","volume":"8","author":"Alavi","year":"2013"},{"issue":"4","key":"10.1016\/j.jmgm.2025.109013_bib14","first-page":"590","article-title":"Idebenone increases chance of stabilization\/recovery of visual acuity in OPA1\u2010dominant optic atrophy","volume":"7","author":"Romagnoli","year":"2020"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109013_bib15","first-page":"e231","article-title":"Idebenone treatment in patients with OPA1-mutant dominant optic atrophy","volume":"136","author":"Barboni","year":"2013"},{"key":"10.1016\/j.jmgm.2025.109013_bib16","first-page":"92","article-title":"A randomized, placebo-controlled trial of the benzoquinone idebenone in a mouse model of OPA1-related dominant optic atrophy reveals a limited therapeutic effect on retinal ganglion cell dendropathy and visual function","volume":"319","author":"Smith","year":"2016"},{"issue":"1","key":"10.1016\/j.jmgm.2025.109013_bib17","first-page":"2468","article-title":"OPA1 gene therapy prevents retinal ganglion cell loss in a dominant optic atrophy mouse model","volume":"8","author":"Sarzi","year":"2018"},{"key":"10.1016\/j.jmgm.2025.109013_bib18","first-page":"199","article-title":"OPA1: how much do we know to approach therapy?","volume":"131","author":"Del Dotto","year":"2018"},{"issue":"10","key":"10.1016\/j.jmgm.2025.109013_bib19","first-page":"3496","article-title":"Deciphering OPA1 mutations pathogenicity by combined analysis of human, mouse and yeast cell models","volume":"1864","author":"Del Dotto","year":"2018"},{"issue":"7765","key":"10.1016\/j.jmgm.2025.109013_bib20","first-page":"429","article-title":"Structure and assembly of the mitochondrial membrane remodelling GTPase Mgm1","volume":"571","author":"Faelber","year":"2019"},{"key":"10.1016\/j.jmgm.2025.109013_bib21","volume":"vol. 9","author":"Zhang","year":"2020"},{"issue":"6","key":"10.1016\/j.jmgm.2025.109013_bib22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1083\/jcb.201308006","article-title":"The i-AAA protease YME1L and OMA1 cleave OPA1 to balance mitochondrial fusion and fission","volume":"204","author":"Anand","year":"2014","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.jmgm.2025.109013_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.50973","article-title":"Two forms of Opa1 cooperate to complete fusion of the mitochondrial inner-membrane","volume":"9","author":"Ge","year":"2020","journal-title":"Elife"},{"issue":"7765","key":"10.1016\/j.jmgm.2025.109013_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/s41586-019-1372-3","article-title":"Structure and assembly of the mitochondrial membrane remodelling GTPase Mgm1","volume":"571","author":"Faelber","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.jmgm.2025.109013_bib25","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1073\/pnas.1919116117","article-title":"Structural analysis of a trimeric assembly of the mitochondrial dynamin-like GTPase Mgm1","volume":"117","author":"Yan","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"3","key":"10.1016\/j.jmgm.2025.109013_bib26","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1042\/EBC20170104","article-title":"Mitochondrial dynamics: overview of molecular mechanisms","volume":"62","author":"Tilokani","year":"2018","journal-title":"Essays Biochem."},{"issue":"Supp 54","key":"10.1016\/j.jmgm.2025.109013_bib27","first-page":"1","article-title":"Infantile optic atrophy with dominant mode of inheritance: a clinical and genetic study of 19 Danish families","volume":"164","author":"Kjer","year":"1959","journal-title":"Acta Ophthalmol. Suppl."},{"issue":"9","key":"10.1016\/j.jmgm.2025.109013_bib28","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1001\/archopht.1979.01020020248013","article-title":"Dominant optic atrophy: the clinical profile","volume":"97","author":"Kline","year":"1979","journal-title":"Arch. Ophthalmol."},{"issue":"10","key":"10.1016\/j.jmgm.2025.109013_bib29","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1136\/jmg.35.10.793","article-title":"Clinical features, molecular genetics, and pathophysiology of dominant optic atrophy","volume":"35","author":"Votruba","year":"1998","journal-title":"J. Med. Genet."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109013_bib30","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/79944","article-title":"OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28","volume":"26","author":"Alexander","year":"2000","journal-title":"Nat. Genet."},{"issue":"2","key":"10.1016\/j.jmgm.2025.109013_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/79936","article-title":"Nuclear gene OPA1, encoding a mitochondrial dynamin-related protein, is mutated in dominant optic atrophy","volume":"26","author":"Delettre","year":"2000","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109013_bib32","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1001\/archopht.117.6.805","article-title":"Genetic heterogeneity of dominant optic atrophy, Kjer type: identification of a second locus on chromosome 18q12. 2-12.3","volume":"117","author":"Kerrison","year":"1999","journal-title":"Arch. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109013_bib33","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1136\/jmg.2004.025502","article-title":"A third locus for dominant optic atrophy on chromosome 22q","volume":"42","author":"Barbet","year":"2005","journal-title":"J. Med. Genet."},{"issue":"6","key":"10.1016\/j.jmgm.2025.109013_bib34","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1086\/324651","article-title":"Type III 3-methylglutaconic aciduria (optic atrophy plus syndrome, or Costeff optic atrophy syndrome): identification of the OPA3 gene and its founder mutation in Iraqi Jews","volume":"69","author":"Anikster","year":"2001","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.jmgm.2025.109013_bib35","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1136\/jmg.39.8.e47","article-title":"Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease","volume":"39","author":"Marchbank","year":"2002","journal-title":"J. Med. Genet."},{"issue":"9","key":"10.1016\/j.jmgm.2025.109013_bib36","first-page":"2271","article-title":"Idebenone treatment increases chances of stabilization-recovery of visual acuity in patients affected by dominant optic atrophy (DOA)","volume":"60","author":"Romagnoli","year":"2019","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jmgm.2025.109013_bib37","first-page":"521","volume":"vol. 28","author":"Yu-Wai-Man","year":"2014"},{"issue":"7","key":"10.1016\/j.jmgm.2025.109013_bib38","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.201907098","article-title":"Structural insights into G domain dimerization and pathogenic mutation of OPA1","volume":"219","author":"Yu","year":"2020","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.jmgm.2025.109013_bib39","series-title":"Marine-derived Compounds as Potential Neuroprotective Agents","author":"Barreiro","year":"2020"},{"issue":"4","key":"10.1016\/j.jmgm.2025.109013_bib40","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/md17040221","article-title":"Marine-derived natural compounds for the treatment of Parkinson's disease","volume":"17","author":"Huang","year":"2019","journal-title":"Mar. Drugs"},{"issue":"2","key":"10.1016\/j.jmgm.2025.109013_bib41","doi-asserted-by":"crossref","first-page":"834","DOI":"10.3390\/ijms25020834","article-title":"From beach to the bedside: harnessing mitochondrial function in human diseases using new marine-derived strategies","volume":"25","author":"Mirra","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jmgm.2025.109013_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.107065","article-title":"Novel quinazolinone Derivatives: design, synthesis and in vivo evaluation as potential agents targeting Alzheimer disease","volume":"143","author":"Moftah","year":"2024","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.jmgm.2025.109013_bib43","article-title":"Chemical characteristics, synthetic methods, and biological potential of quinazoline and quinazolinone derivatives","volume":"2014","author":"Asif","year":"2014","journal-title":"Int J Med Chem"},{"issue":"13","key":"10.1016\/j.jmgm.2025.109013_bib44","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera--a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J. Comput. Chem."},{"issue":"D1","key":"10.1016\/j.jmgm.2025.109013_bib45","doi-asserted-by":"crossref","first-page":"D1373","DOI":"10.1093\/nar\/gkac956","article-title":"PubChem 2023 update","volume":"51","author":"Kim","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.jmgm.2025.109013_bib46","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1021\/ci049885e","article-title":"LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters","volume":"45","author":"Wolber","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"12","key":"10.1016\/j.jmgm.2025.109013_bib47","doi-asserted-by":"crossref","first-page":"6065","DOI":"10.1021\/acs.jcim.0c00675","article-title":"ZINC20\u2014a free ultralarge-scale chemical database for ligand discovery","volume":"60","author":"Irwin","year":"2020","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2025.109013_bib48","series-title":"Chemical Biology: Methods and Protocols","first-page":"243","article-title":"Small-molecule library screening by docking with PyRx","author":"Dallakyan","year":"2015"},{"key":"10.1016\/j.jmgm.2025.109013_bib49","volume":"vol. 4","author":"Biovia","year":"2015"},{"issue":"20","key":"10.1016\/j.jmgm.2025.109013_bib50","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1063\/1.1808117","article-title":"A modified TIP3P water potential for simulation with Ewald summation","volume":"121","author":"Price","year":"2004","journal-title":"J. Chem. Phys."},{"issue":"14","key":"10.1016\/j.jmgm.2025.109013_bib51","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2174\/1568026616666161117112604","article-title":"A comprehensive docking and MM\/GBSA rescoring study of ligand recognition upon binding antithrombin","volume":"17","author":"Zhang","year":"2017","journal-title":"Curr. Top. Med. Chem."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326325000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T12:46:10Z","timestamp":1746103570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326325000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":51,"alternative-id":["S1093326325000737"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109013","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting OPA1 protein for therapeutic intervention in autosomal dominant optic atrophy: In silico drug discovery","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2025.109013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109013"}}